194 related articles for article (PubMed ID: 21591997)
21. The role of clofarabine in acute myeloid leukemia.
Ghanem H; Kantarjian H; Ohanian M; Jabbour E
Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
[TBL] [Abstract][Full Text] [Related]
22. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Kantarjian H; Gandhi V; Cortes J; Verstovsek S; Du M; Garcia-Manero G; Giles F; Faderl S; O'Brien S; Jeha S; Davis J; Shaked Z; Craig A; Keating M; Plunkett W; Freireich EJ
Blood; 2003 Oct; 102(7):2379-86. PubMed ID: 12791647
[TBL] [Abstract][Full Text] [Related]
24. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review.
Kline JP; Larson RA
Expert Opin Pharmacother; 2005 Dec; 6(15):2711-8. PubMed ID: 16316309
[TBL] [Abstract][Full Text] [Related]
25. Clofarabine.
Pui CH; Jeha S
Nat Rev Drug Discov; 2005 May; Suppl():S12-3. PubMed ID: 15962525
[TBL] [Abstract][Full Text] [Related]
26. Clofarabine in leukemia.
Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
[TBL] [Abstract][Full Text] [Related]
27. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
[TBL] [Abstract][Full Text] [Related]
28. Novel purine nucleoside analogues for hematological malignancies.
Korycka A; Lech-Marańda E; Robak T
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
[TBL] [Abstract][Full Text] [Related]
29. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
Jeha S; Gandhi V; Chan KW; McDonald L; Ramirez I; Madden R; Rytting M; Brandt M; Keating M; Plunkett W; Kantarjian H
Blood; 2004 Feb; 103(3):784-9. PubMed ID: 14551141
[TBL] [Abstract][Full Text] [Related]
30. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
[TBL] [Abstract][Full Text] [Related]
31. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
Steinherz PG; Meyers PA; Steinherz LJ; Jeha S
J Pediatr Hematol Oncol; 2007 Sep; 29(9):656-8. PubMed ID: 17805046
[TBL] [Abstract][Full Text] [Related]
32. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
[TBL] [Abstract][Full Text] [Related]
33. A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
Faderl S; Garcia-Manero G; Jabbour E; Ravandi F; Borthakur G; Estrov Z; Gandhi V; Byrd AL; Kwari M; Cortes J; Kantarjian HM
Cancer; 2012 Feb; 118(3):722-8. PubMed ID: 21751197
[TBL] [Abstract][Full Text] [Related]
34. Clofarabine-induced acral erythema during the treatment of patients with myelodysplasia and acute leukemia: report of two cases.
Chiao N; Bumgardner A; Duvic M
Leuk Lymphoma; 2003 Aug; 44(8):1405-7. PubMed ID: 12952235
[TBL] [Abstract][Full Text] [Related]
35. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.
Huguet F; Leguay T; Raffoux E; Rousselot P; Vey N; Pigneux A; Ifrah N; Dombret H
Leuk Lymphoma; 2015 Apr; 56(4):847-57. PubMed ID: 24996442
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia].
Suo P; Zhang LP; Wu J; Lu AD; Wang B; Zuo YX; Cheng YF; Liu GL
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):444-7. PubMed ID: 23791059
[TBL] [Abstract][Full Text] [Related]
37. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
Burnett AK; Russell NH; Kell J; Dennis M; Milligan D; Paolini S; Yin J; Culligan D; Johnston P; Murphy J; McMullin MF; Hunter A; Das-Gupta E; Clark R; Carr R; Hills RK
J Clin Oncol; 2010 May; 28(14):2389-95. PubMed ID: 20385984
[TBL] [Abstract][Full Text] [Related]
38. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Larson RA
Semin Oncol; 2007 Dec; 34(6 Suppl 5):S13-20. PubMed ID: 18086342
[TBL] [Abstract][Full Text] [Related]
39. Novel therapies for myelodysplastic syndromes.
Steensma DP
Hematol Oncol Clin North Am; 2010 Apr; 24(2):423-41. PubMed ID: 20359635
[TBL] [Abstract][Full Text] [Related]
40. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M
Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
